Docoh
Loading...

BAX Baxter International

Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Company profile

Ticker
BAX
Exchange
Website
CEO
Jose Almeida
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
360781620

BAX stock data

(
)

Calendar

11 Feb 21
18 Apr 21
31 Dec 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 3.74B 3.74B 3.74B 3.74B 3.74B 3.74B
Cash burn (monthly) 210M (positive/no burn) (positive/no burn) (positive/no burn) (positive/no burn) (positive/no burn)
Cash used (since last report) 759.69M n/a n/a n/a n/a n/a
Cash remaining 2.98B n/a n/a n/a n/a n/a
Runway (months of cash) 14.2 n/a n/a n/a n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
12 Apr 21 Frye Andrew Common Stock, $1 par value Sell Dispose S No Yes 84.79 10,999 932.61K 9,041
5 Apr 21 Hellman Peter S Common Stock, $1 par value Sell Dispose S No No 84.56 4,990 421.95K 25,399
5 Apr 21 Hellman Peter S Common Stock, $1 par value Option exercise Aquire M No Yes 31.26 4,990 155.99K 30,389
5 Apr 21 Hellman Peter S Stock Option Common Stock, $1 par value Option exercise Dispose M No Yes 31.26 4,990 155.99K 0
5 Apr 21 Stroucken Albert P L Common Stock, $1 par value Sell Dispose S No No 84.56 4,990 421.95K 31,896
5 Apr 21 Stroucken Albert P L Common Stock, $1 par value Option exercise Aquire M No Yes 31.26 4,990 155.99K 36,886
5 Apr 21 Stroucken Albert P L Stock Option Common Stock, $1 par value Option exercise Dispose M No Yes 31.26 4,990 155.99K 0
22 Mar 21 Stevens Brian Common Stock, $1 par value Payment of exercise Dispose F No No 81.24 155 12.59K 18,854
3 Mar 21 Almeida Jose E Stock Option Common Stock, $1 par value Grant Aquire A No No 77.15 348,483 26.89M 348,483
6 Jan 21 Hellman Peter S Stock Option Common Stock, $1 par value Gift Aquire G Yes No 88.74 5,293 469.7K 5,293

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

84.6% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 1076 1067 +0.8%
Opened positions 118 79 +49.4%
Closed positions 109 122 -10.7%
Increased positions 322 336 -4.2%
Reduced positions 398 408 -2.5%
13F shares
Current Prev Q Change
Total value 34.3B 34.04B +0.8%
Total shares 427.39M 423.36M +1.0%
Total puts 1.28M 1.49M -14.3%
Total calls 1.39M 1.47M -5.6%
Total put/call ratio 0.9 1.0 -9.2%
Largest owners
Shares Value Change
Wellington Management 41.37M $3.32B +43.9%
BLK Blackrock 40.94M $3.28B -8.2%
Vanguard 39.18M $3.14B -0.6%
MS Morgan Stanley 24.07M $1.93B +1.0%
STT State Street 21.05M $1.69B -5.2%
Generation Investment Management 17.42M $1.4B +46.9%
Capital International Investors 12.54M $1.01B +4.9%
Veritas Asset Management 11.11M $891.48M +1.4%
Capital World Investors 9.32M $747.52M +77.6%
AMP Ameriprise Financial 8.5M $682.06M -1.7%
Largest transactions
Shares Bought/sold Change
Wellington Management 41.37M +12.62M +43.9%
Norges Bank 5.92M +5.92M NEW
Generation Investment Management 17.42M +5.57M +46.9%
JPM JPMorgan Chase & Co. 2.77M -4.36M -61.1%
Capital World Investors 9.32M +4.07M +77.6%
BLK Blackrock 40.94M -3.66M -8.2%
MKFCF Mackenzie Financial 188.18K -3.45M -94.8%
FMR 983.72K -3.11M -76.0%
Mawer Investment Management 921.29K -2.32M -71.6%
D1 Capital Partners 2.05M +2.05M NEW
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: acid, admission, Alcoa, Aluminum, amino, appeal, BaxU, BD, Black, BofA, Borzi, Caelyx, CAGR, cancer, cease, chemotherapy, choice, Citigroup, cleaning, content, crucial, cybersecurity, default, Delinquent, Deutsche, divestiture, Doxil, doxorubicin, economy, encompassing, encourage, EPA, escalating, ESRD, faith, feedback, firmly, frequency, gave, GlaxoSmithKline, Goldman, GPA, Grandfathered, Hydro, induce, infection, influence, insolvency, interbank, Johnson, learning, Lennox, LIBOR, lieu, liposomal, logistical, London, lump, Marketplace, mindset, monthly, motivate, movement, multidimensional, nausea, NAV, nonrecurring, OUS, Overnight, petitioning, platform, postponed, preferential, prioritize, prioritized, pronouncement, proper, racial, ran, remote, remotely, resumption, retaliation, retention, revert, revocation, rooted, run, Rupee, sanitation, shelter, shown, SOFR, spread, sum, superior, Supreme, survey, tariff, tasked, telecommunication, Today, transplantation, tuition, underway, unemployment, unintended, unprecedented, virtual, vital, vomiting, widely
Removed: assume, attended, book, bribery, consultation, continuously, cooperating, cover, cyclophosphamide, deconsolidated, deconsolidating, deconsolidation, demanding, derived, desired, ending, FASB, feasibility, Fifty, financially, fiscal, galaxy, implied, imposition, indirectly, integrating, interim, investigative, Irvine, Jayuya, moving, MSA, partial, presidential, prosecution, reallocation, repatriated, resolved, salary, simplify, split, stake, Supplementary, technique, trademark, TSA, Venezuela, Venezuelan, volume, weakening, Western, windfall

Patents

GRANT
Utility
Control of a water device via a dialysis machine user interface
13 Apr 21
A home medical device system includes a home therapy machine for performing a home therapy on a patient; a user interface operably connected to the home therapy machine, the user interface receiving operator inputs; a water treatment device in fluid communication with the home therapy machine; and a data connection between the home therapy machine and the water treatment device, wherein the home therapy machine transmits data via the connection to the water treatment device for control of the water treatment device, the data provided based on at least one of the operator inputs received via the user interface.
GRANT
Utility
Irradiated membrane for cell expansion
13 Apr 21
A membrane for cultivating adherent or suspension cells, in particular adherent cells.
GRANT
Utility
Bar-type parameter adjustment elements
13 Apr 21
Graphical user interfaces for use with extracorporeal blood treatment systems may include one or more bar-type parameter adjustment elements.
APP
Utility
Fluid Temperature Control Device for an Extracorporeal Blood Treatment Apparatus and Extracorporeal Blood Treatment Apparatus
8 Apr 21
A fluid temperature control device for an extracorporeal blood treatment apparatus, comprises: a casing (26) delimiting a heating/cooling seat (20) configured to accommodate a fluid warming bag (17) connected or connectable to an extracorporeal blood treatment apparatus (1); heating elements (29, 30) operatively active in the heating seat (20) to heat the fluid warming bag (17); at least a presence detector (32, 33) operatively active in the heating seat (20) to detect the presence of the fluid warming bag (17).
APP
Utility
a Connector Arrangement, a System for Extracorporeal Blood Treatment and a Method for Priming a Fluid Chamber of a Blood Treatment Unit
8 Apr 21
A connector arrangement (10) for connecting to a fluid chamber (6) of a blood treatment unit (4) for extracorporeal blood treatments.